43 For example, the expression of ICAM-1 in asthma patients was significantly higher than in healthy controls, and more markedly significant differences were observed in severe asthma attacks. 44 Thus, methods to reduce ICAM-1 and VCAM-1 expression would be of interest in the development of novel therapeutic methods for asthma.
← all excerpts
Attenuation of airway inflammation by simvastatin and the implications for asthma treatment: is the jury still out?
1
—
—